Metabolic Diseases Clinical Trials

38 recruitingLast updated: June 18, 2026

There are 38 actively recruiting metabolic diseases clinical trials across 21 countries. Studies span Not Applicable, Phase 2, Phase 3, Phase 1, Phase 4. Top locations include Boston, Massachusetts, United States, Shanghai, China, Dallas, Texas, United States. Updated daily from ClinicalTrials.gov.


Metabolic Diseases Trials at a Glance

38 actively recruiting trials for metabolic diseases are listed on ClinicalTrialsFinder across 6 cities in 21 countries. The largest study group is Not Applicable with 18 trials, with the heaviest enrollment activity in Boston, Shanghai, and Dallas. Lead sponsors running metabolic diseases studies include Massachusetts General Hospital, University of Texas Southwestern Medical Center, and Assistance Publique - Hôpitaux de Paris.

Browse metabolic diseases trials by phase

Treatments under study

About Metabolic Diseases Clinical Trials

Looking for clinical trials for Metabolic Diseases? There are currently 19 studies actively recruiting participants. Clinical trials offer access to new treatments before they are widely available, and every approved therapy in use today was first tested through a clinical trial.

Below you can browse trials, sign up for alerts when new Metabolic Diseases trials open, and view eligibility criteria for each study. Each listing includes the study phase, locations, and enrollment details.

Frequently Asked Questions

Common questions about Metabolic Diseases clinical trials

A clinical trial is a carefully designed research study that tests new medical treatments, drugs, devices, or approaches in human volunteers. Every approved medication and treatment available today was proven safe and effective through clinical trials.

All clinical trials are reviewed and approved by Institutional Review Boards (IRBs) — independent committees that evaluate patient safety. Trials follow strict protocols, and your health is monitored closely throughout. You can withdraw at any time.

Not necessarily. Many trials compare the new treatment against the current standard of care, meaning all participants receive active treatment. When placebos are used, they are typically combined with standard treatment, not given alone. The trial description will always specify the design.

Under the Affordable Care Act, most private insurers are required to cover routine patient care costs during a clinical trial. The sponsor typically covers the investigational treatment itself. Medicare also covers routine costs for qualifying trials.

Yes. Participation is completely voluntary. You can withdraw at any time, for any reason, without it affecting your access to standard medical care.

Each trial has specific eligibility criteria — including age, diagnosis, disease stage, prior treatments, and general health. Browse the trials listed above and check their eligibility sections. You can also contact the trial site directly to discuss your situation.

Showing 120 of 38 trials

Recruiting
Phase 2

A Study of PF-08653945 and PF-08653944 in Adults With Overweight or Obesity (SOLIS-1)

ObesityBody WeightOverweight+5 more
Pfizer872 enrolled48 locationsNCT07575932
Recruiting
Phase 1

FES Cycling With BFR in the Spinal Cord Injury Population

Spinal Cord InjuryMetabolic Diseases, Type 2 Diabetes, Cardiovascular DiseaseCardio Vascular Disease
Dr. B. Catharine. Craven6 enrolled1 locationNCT07588503
Recruiting
Not Applicable

Blood Lipid Responses to Diet Macronutrients

Nutritional and Metabolic Diseases
University of Oxford60 enrolled2 locationsNCT05973539
Recruiting
Not Applicable

Health Chat for Empowerment-based Lifestyle Planning for Cardiometabolic Multimorbidity

Cardiometabolic DiseasesMultimorbidity
The University of Hong Kong232 enrolled3 locationsNCT07158697
Recruiting

Cardiometabolic Disease and Substrate Metabolism

Insulin ResistancePregnancyPregnancy Complications+9 more
University of Tennessee Graduate School of Medicine50 enrolled1 locationNCT07565727
Recruiting

Study on Construction of Whole Lifecycle Cohort, Big Data Management and Clinical Prognosis of Cardio-Renal-Metabolic (CKM) Syndrome

Chronic Kidney DiseaseMetabolic DiseasesCardiovascular Diseases (CVD)+1 more
First Affiliated Hospital of Fujian Medical University8,000 enrolled1 locationNCT07547098
Recruiting
Phase 3

A Phase 3 Study of NTLA-2001 in ATTRv-PN

Nervous system diseasePeripheral nervous system diseaseAmyloidosis+17 more
Intellia Therapeutics60 enrolled14 locationsNCT06672237
Recruiting
Phase 4

GLUCOSE-MGH: Genetic Links Understood Through Challenge With Oral Semaglutide Exposure at MGH

Genetic PredispositionType 2 DiabetesMetabolic Diseases
Massachusetts General Hospital125 enrolled1 locationNCT06003153
Recruiting
Not Applicable

GENESIS: Genotype Guided - Natriuretic Peptides - Cardiometabolic Health Study

Glucose metabolismExerciseObesity+4 more
University of Alabama at Birmingham200 enrolled1 locationNCT05216042
Recruiting

Evaluation of Therapeutic Adherence Among Patients Followed in the Department of Hereditary Metabolic Diseases at Necker Hospital

Metabolic Diseases
Assistance Publique - Hôpitaux de Paris200 enrolled1 locationNCT07356557
Recruiting
Not Applicable

Whole Food for Families: A Pilot RCT of a Dietary Guidelines-Based Intervention to Prevent Type 2 Diabetes

Diet, HealthyPrediabetesNutritional and Metabolic Diseases
Vanderbilt University30 enrolled1 locationNCT06482944
Recruiting
Not Applicable

NT-ProBNP-based Heart Failure Screening and Prevention Trial in Patients With Type 2 Diabetes: STRONG-DM Study

Heart FailureType 2 DiabetesDiabetic Cardiomyopathy+1 more
University of Texas Southwestern Medical Center300 enrolled1 locationNCT06593327
Recruiting

Magnetic Resonance Imaging in Metabolic Diseases

Metabolic Diseases
University of Ulm126 enrolled1 locationNCT06709846
Recruiting
Not Applicable

The Satiety Control Optimization by Nutritional Enhancement Study

Metabolic Diseases, Type 2 Diabetes, Cardiovascular Disease
University College Cork24 enrolled1 locationNCT07420023
Recruiting
Not Applicable

Effects of Daily Beef Intake, as a Component of a Heart-Healthy Diet on Cellular Zinc

InflammationVascular DiseasesMetabolic Diseases+1 more
University of California, Davis20 enrolled1 locationNCT05236374
Recruiting

Landscape of Gout in French Polynesia.

InflammationMetabolic DiseasesGout Disease
Lille Catholic University2,750 enrolled6 locationsNCT07343336
Recruiting
Not Applicable

Sustainable Diets and Cardiometabolic Health

Cardiometabolic Diseases
University of Copenhagen180 enrolled1 locationNCT07189676
Recruiting
Not Applicable

The FaibaGo Study - Long-Term Weight Reduction Via Low-Threshold Intervention

OverweightNutritional and Metabolic Diseases
University of Bern120 enrolled1 locationNCT07036692
Recruiting
Not Applicable

Impact of Earplugs on Mechanisms of Noise-Related Cardiovascular Disease

Cardiometabolic DiseasesNoise exposure
Massachusetts General Hospital26 enrolled1 locationNCT07148817
Recruiting
Not Applicable

Effects of HIIT vs. TRE on Type 2 Diabetes Risk

Time Restricted EatingHigh-intensity Interval TrainingObesity and Type 2 Diabetes+1 more
Syracuse University40 enrolled1 locationNCT07215533